Public health & disease

Colorful ribbons on pink background

New drug offers breakthrough in treatment of asbestos-linked cancer

| By | -, Change Milestones

Scientists at Queen Mary University of London have developed a drug to treat mesothelioma, a notoriously deadly and hard-to-treat cancer linked to asbestos, in the biggest breakthrough in two decades.
An international trial spanning five countries found that the new drug, ADI-PEG20, cuts off the tumor’s food supply and quadruples three-year survival rates. It is the first of its kind to be successfully combined with chemotherapy in 20 years.

New drug offers breakthrough in treatment of asbestos-linked cancer Read more

Assortment of pills

Novel AI model rapidly determines if an antidepressant will work

| By | -, Change Milestones

Amsterdam University Medical Center (UMC) and Radboud UMC researchers have developed an algorithm that, based on patient MRI scans and other data, can determine within a week if a particular antidepressant will, offering faster relief and minimizing often painful and damaging side effects. “This is important news for patients,” said Liesbeth Reneman, Professor of Neuroradiology at Amsterdam UMC. “Normally, it takes six to eight weeks before it is known whether an antidepressant will work.”

Novel AI model rapidly determines if an antidepressant will work Read more

Depiction of nerve cells

Researchers discover an effective non-opioid treatment for nerve pain

| By | -, Change Milestones

Many available pain medications aren’t effective in reducing this often-debilitating type of chronic pain. However, researchers at the University of Texas at Austin (UT Austin), in collaboration with UT Dallas and the University of Miami, may have advanced the treatment of neuropathic pain by discovering a molecule that reduces mechanical hypersensitivity in mice.

Researchers discover an effective non-opioid treatment for nerve pain Read more

Chromosomes

Gene therapy hailed as ‘medical magic wand’ for hereditary swelling disorder

| By | -, Change Milestones

Hereditary angioedema, or HAE, is a rare disease that affects about one in 50,000 people. It is caused by a genetic mutation that leaves patients with leaky blood vessels, causing erratic bouts of swelling. Dr. Hilary Longhurst, the principal investigator at New Zealand’s Te Toka Tumai, Auckland City hospital, said the new single-dose therapy appeared to provide a permanent cure for her patients’ “very disabling symptoms”.

Gene therapy hailed as ‘medical magic wand’ for hereditary swelling disorder Read more

Back of a school bus

Miami commits to putting 100 electric school buses on the road

| By | -, Change Milestones

Miami-Dade county is set to receive nearly $20 million from the Environmental Protection Agency to help cover the costs of 50 new electric school buses and 16 DC fast chargers, bringing the public school district’s total to 100 electric buses. Miami-Dade county is one of four school districts selected to receive a total of $33,175,000 through the EPA’s first Clean School Bus Program’s Grants Competition.

Miami commits to putting 100 electric school buses on the road Read more

Person having blood drawn

Breakthrough Alzheimer’s blood test could detect disease 15 years before symptoms emerge

| By | -, Change Milestones

A recent trial of 786 people – conducted by Dr. Nicholas Ashton at the University of Gothenburg in Sweden and colleagues – found the new test to be as accurate at detecting the signs of Alzheimer’s as painful lumbar punctures, and better than a range of other tests currently being worked on. Experts say it could pave the way for national screening programs for people 50 and over, and that current treatments could work better with the cases picked up earlier.

Breakthrough Alzheimer’s blood test could detect disease 15 years before symptoms emerge Read more

Mosquito

Historic malaria vaccine rollout begins in Cameroon

| By | -, Change Milestones

The rollout of the world’s first malaria vaccine has begun in Cameroon, which is said to usher in a “transformative chapter in Africa’s public health history”. The RTS,S vaccine – 662,000 doses of it – will be administered to children in the west African country, the first to be vaccinated after successful trials of the drug in Ghana, Kenya, and Malawi between 2019 and 2021.

Historic malaria vaccine rollout begins in Cameroon Read more

Manhattan skyline

New York City plans to wipe out $2 billion in medical debt for 500,000 residents

| By | -, Change Milestones

The city is working with RIP Medical Debt, a nonprofit that buys medical debt in bulk from hospitals and debt collectors for pennies on the dollar. The group targets the debt of people with low incomes or financial hardships and then forgives the amounts. Under the program, the city will spend $18 million over three years.

New York City plans to wipe out $2 billion in medical debt for 500,000 residents Read more

Doctor holding vial of HPV vaccine

No cervical cancer cases in HPV-vaccinated women in Scotland

| By | -, Change Milestones

A new study from Public Health Scotland has found that no cases of cervical cancer have been detected in young women who have been fully-vaccinated as part of the HPV immunization program, concluding that the vaccine was “highly effective” in preventing the development of the cancer. Scotland’s HPV vaccination program started in 2008 with girls offered the vaccine in their first year at secondary school.

No cervical cancer cases in HPV-vaccinated women in Scotland Read more

Start typing and press enter to search